RaxarActive Ingredient(s): Grepafloxacin
FDA Approved: * November 6, 1997
Pharm Company: * OTSUKA
Grepafloxacin (trade name Raxar, Glaxo Wellcome) was an oral broad-spectrum fluoroquinolone antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn worldwide from markets in 1999, due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death. Contents 1 Clinical uses 2 Synthesis 3 Stereochemistry 4 See also 5 References Clinical uses Grepafl... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.